Tris Pharma, Inc. — Form D
Tris Pharma, Inc. of MONMOUTH JUNCTION, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-04. The offering totals $167.5M, of which $125.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-10-04
- Form: D
- Accession: 0001754826-18-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $167.5M
- Amount sold: $125.0M
- Remaining: $42.5M
- Minimum investment: $15.0M
- Investors: 3
- Date of first sale: 2018-09-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-322786
Issuer
- Name: Tris Pharma, Inc.
- CIK: 0001754826
- Entity type: Corporation
- Jurisdiction: NEW JERSEY
- Address: 2033 ROUTE 130, MONMOUTH JUNCTION, NJ, 08852
- Phone: 732-823-4926
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ketan Mehta | Director | Englewood, CO |
| Smita Mehta | Director | Scottsdale, AZ |
| Peter Ciano | Executive Officer | Monmouth Junction, NJ |
| Ketan Mehta | Executive Officer | Englewood, CO |
More